National Quality Measures Clearinghouse | Measures by Topic: Breast Neoplasms

National Quality Measures Clearinghouse | Measures by Topic: Breast Neoplasms

October 7, 2013

Measures by Topic

Disease/Condition >Diseases (1463) > Neoplasms (181) > Neoplasms by Site (118) >

Breast Neoplasms (32)

Narrow:

Breast Neoplasms, Male (15)
Carcinoma, Ductal, Breast (3)

Breast Neoplasms, Male (15)
Carcinoma, Ductal, Breast (3)

'' (Clear)

and '' (Clear)

Search Within Search within: Go

Sort results by: Relevance (what's this?) Publication date

Filter results by: All Years2013201220112010200920082007200620052004200320022001200019971990

1-20 of 32 Next >
1. Breast cancer screening: percentage of women 40 to 69 years of age who had a mammogram to screen for breast cancer. 2012 Sep. NQMC:008168 National Committee for Quality Assurance - Health Care Accreditation Organization. View all measures by the developer(s) Compare Selected
2. Preventive services for adults: percentage of female patients ages 50 to 75 years who have screening for breast cancer every one to two years. 2012 Sep. NQMC:008140 Institute for Clinical Systems Improvement - Nonprofit Organization. View all measures by the developer(s) Compare Selected
3. Oncology: percentage of pre-menopausal patients with stage II carcinoma of the breast for whom there is documented evidence of treatment, or intention to treat, with poly-chemotherapy, during the 6 month time period. 2012 Jan. NQMC:007805 Australian Council on Healthcare Standards - Health Care Accreditation Organization. View all measures by the developer(s) Compare Selected
4. Radiation oncology: percentage of patients who had radiotherapy for breast conservation (pT1-3, any nodal staging, M0), during the 6 month time period, who had complete follow-up. 2012 Jan. NQMC:007914 Australian Council on Healthcare Standards - Health Care Accreditation Organization. View all measures by the developer(s) Compare Selected
5. Imaging efficiency: percentage of patients with mammography screening studies that are followed by a diagnostic mammography, ultrasound or MRI of the breast in an outpatient or office setting within 45 days. 2011 Dec. [NQMC Update Pending] NQMC:006362 Centers for Medicare & Medicaid Services - Federal Government Agency [U.S.]. View all measures by the developer(s) Compare Selected
6. Preventive services: percentage of adult enrolled members ages 19 years and older who are up-to-date for all appropriate preventive services. 2011 Oct. [NQMC Update Pending] NQMC:006906 HealthPartners - Managed Care Organization. View all measures by the developer(s) Compare Selected
7. Oncology: percentage of patients, regardless of age, with a diagnosis of breast, colon, or rectal cancer who are receiving intravenous chemotherapy for whom the planned chemotherapy regimen (which includes, at a minimum: drug[s] prescribed, dose, and duration) is documented prior to the initiation of the new treatment regimen. 2010 Sep. NQMC:003764 American Society for Therapeutic Radiology and Oncology - Medical Specialty Society; American Society of Clinical Oncology - Medical Specialty Society; Physician Consortium for Performance Improvement® - Clinical Specialty Collaboration. View all measures by the developer(s) Compare Selected
8. Oncology: percentage of patients, regardless of age, with a diagnosis of breast, colon, or rectal cancer who are seen in the ambulatory setting who have a baseline AJCC cancer stage or documentation that the cancer is metastatic in the medical record at least once during the 12 month reporting period. 2010 Sep. NQMC:003761 American Society for Therapeutic Radiology and Oncology - Medical Specialty Society; American Society of Clinical Oncology - Medical Specialty Society; Physician Consortium for Performance Improvement® - Clinical Specialty Collaboration. View all measures by the developer(s) Compare Selected
9. Pathology: percentage of breast cancer resection pathology reports that include the pT category (primary tumor), the pN category (regional lymph nodes) and the histologic grade. 2010 Sep. NQMC:003482 College of American Pathologists - Medical Specialty Society; Physician Consortium for Performance Improvement® - Clinical Specialty Collaboration. View all measures by the developer(s) Compare Selected
10. Radiology: percentage of final reports for screening mammograms that are classified "probably benign." 2010 Sep. NQMC:004954 American College of Radiology - Medical Specialty Society; National Committee for Quality Assurance - Health Care Accreditation Organization; Physician Consortium for Performance Improvement® - Clinical Specialty Collaboration. View all measures by the developer(s) Compare Selected
11. Radiology: percentage of patients aged 40 years and older undergoing a screening mammogram whose information is entered into a reminder system with a target due date for the next mammogram. 2010 Sep. NQMC:004957 American College of Radiology - Medical Specialty Society; National Committee for Quality Assurance - Health Care Accreditation Organization; Physician Consortium for Performance Improvement® - Clinical Specialty Collaboration. View all measures by the developer(s) Compare Selected
12. Radiology: percentage of patients undergoing diagnostic mammograms that are classified as "suspicious" or "highly suggestive of malignancy" with documentation of direct communication of findings from the diagnostic mammogram to the patient within 5 business days of exam interpretation. 2010 Sep. NQMC:004956 American College of Radiology - Medical Specialty Society; National Committee for Quality Assurance - Health Care Accreditation Organization; Physician Consortium for Performance Improvement® - Clinical Specialty Collaboration. View all measures by the developer(s) Compare Selected
13. Radiology: percentage of patients undergoing diagnostic mammograms that are classified as "suspicious" or "highly suggestive of malignancy" with documentation of direct communication of findings from the diagnostic mammogram to the practice that manages the patient's on-going care within 3 business days of exam interpretation. 2010 Sep. NQMC:004955 American College of Radiology - Medical Specialty Society; National Committee for Quality Assurance - Health Care Accreditation Organization; Physician Consortium for Performance Improvement® - Clinical Specialty Collaboration. View all measures by the developer(s) Compare Selected
14. Radiology: percentage of patients undergoing screening mammograms whose assessment category (e.g., Mammography Quality Standards Act [MQSA], Breast Imaging Reporting and Data System [BI-RADS®], or FDA approved equivalent categories) is entered into an internal database that will, at a minimum, allow analysis of abnormal interpretation (recall) rate. 2010 Sep. NQMC:004953 American College of Radiology - Medical Specialty Society; National Committee for Quality Assurance - Health Care Accreditation Organization; Physician Consortium for Performance Improvement® - Clinical Specialty Collaboration. View all measures by the developer(s) Compare Selected
15. Breast cancer: proportion of patients with malignant diagnoses in the definitive pathology report. 2010 Jun. NQMC:007401 European Society of Breast Cancer Specialists - Clinical Specialty Collaboration. View all measures by the developer(s) Compare Selected
16. Breast cancer: the proportion of invasive cancer cases with primary surgery, for which the following prognostic/predictive parameters have been recorded: histological type; grading (according to EU guidelines); ER & PgR; HER 2; pathological stage (T and N); size in mm for the invasive component; peritumoral vascular invasion; and distance to nearest radial margin. 2010 Jun. NQMC:007403 European Society of Breast Cancer Specialists - Clinical Specialty Collaboration. View all measures by the developer(s) Compare Selected
17. Breast cancer: the proportion of non-invasive cancer cases for which the following prognostic/predictive parameters have been recorded: dominant histologic pattern; size in mm (best pathology or radiology estimate if 2 stage pathology); grading (according to EU Guidelines); and distance to nearest radial margin. 2010 Jun. NQMC:007404 European Society of Breast Cancer Specialists - Clinical Specialty Collaboration. View all measures by the developer(s) Compare Selected
18. Breast cancer: the proportion of patients (DCIS only) who received just one operation (excluding reconstruction). 2010 Jun. NQMC:007406 European Society of Breast Cancer Specialists - Clinical Specialty Collaboration. View all measures by the developer(s) Compare Selected
19. Breast cancer: the proportion of patients (invasive cancer only) who received a single (breast) operation for the primary tumour (excluding reconstruction). 2010 Jun. NQMC:007405 European Society of Breast Cancer Specialists - Clinical Specialty Collaboration. View all measures by the developer(s) Compare Selected
20. Breast cancer: the proportion of patients with breast cancer (invasive or in situ) who had a pre-operative definitive diagnosis (B5 or C5). 2010 Jun. NQMC:007402 European Society of Breast Cancer Specialists - Clinical Specialty Collaboration. View all measures by the developer(s) Compare Selected
1-20 of 32 Next > Measures by Topic Disease/Condition >Diseases (1463) > Neoplasms (181) > Neoplasms by Site (118) > Breast Neoplasms (32) Narrow: Breast Neoplasms, Male (15) Carcinoma, Ductal, Breast (3) Breast Neoplasms, Male (15) Carcinoma, Ductal, Breast (3) '' (Clear) and '' (Clear) Search Within Search within: Go Sort results by: Relevance (what's this?) Publication date Filter results by: All Years2013201220112010200920082007200620052004200320022001200019971990 21-32 of 32 < Previous 21. Breast cancer: the proportion of patients with DCIS who do not undergo axillary clearance. 2010 Jun. NQMC:007411 European Society of Breast Cancer Specialists - Clinical Specialty Collaboration. View all measures by the developer(s) Compare Selected 22. Breast cancer: the proportion of patients with endocrine sensitive invasive carcinoma who received hormonotherapy. 2010 Jun. NQMC:007413 European Society of Breast Cancer Specialists - Clinical Specialty Collaboration. View all measures by the developer(s) Compare Selected 23. Breast cancer: the proportion of patients with ER- (T > 1 cm or Node+) invasive carcinoma who received adjuvant chemotherapy. 2010 Jun. NQMC:007414 European Society of Breast Cancer Specialists - Clinical Specialty Collaboration. View all measures by the developer(s) Compare Selected 24. Breast cancer: the proportion of patients with invasive breast cancer (M0) who received post-operative radiotherapy after surgical resection of the primary tumour and appropriate axillary staging/surgery in the framework of BCT. 2010 Jun. NQMC:007408 European Society of Breast Cancer Specialists - Clinical Specialty Collaboration. View all measures by the developer(s) Compare Selected 25. Breast cancer: the proportion of patients with invasive breast cancer not greater than 3 cm (total size, including DCIS component) who underwent BCT. 2010 Jun. NQMC:007409 European Society of Breast Cancer Specialists - Clinical Specialty Collaboration. View all measures by the developer(s) Compare Selected 26. Breast cancer: the proportion of patients with invasive breast cancer with pN0 who do not undergo axillary clearance. 2010 Jun. NQMC:007412 European Society of Breast Cancer Specialists - Clinical Specialty Collaboration. View all measures by the developer(s) Compare Selected 27. Breast cancer: the proportion of patients with invasive cancer and axillary clearance performed who had at least 10 lymph nodes examined. 2010 Jun. NQMC:007407 European Society of Breast Cancer Specialists - Clinical Specialty Collaboration. View all measures by the developer(s) Compare Selected 28. Breast cancer: the proportion of patients with N+ or N- T > 1 cm HER2+ (IHC 3+ or FISH+) invasive carcinoma treated with chemotherapy and who had adjuvant trastuzumab. 2010 Jun. NQMC:007415 European Society of Breast Cancer Specialists - Clinical Specialty Collaboration. View all measures by the developer(s) Compare Selected 29. Breast cancer: the proportion of patients with non-invasive breast cancer not greater than 2 cm who underwent BCT. 2010 Jun. NQMC:007410 European Society of Breast Cancer Specialists - Clinical Specialty Collaboration. View all measures by the developer(s) Compare Selected 30. Osteoporosis: percentage of patients aged 18 years and older with one of the following conditions or therapies: receiving oral glucocorticosteroid therapy for greater than 3 months OR hypogonadism OR fracture history OR transplant history OR obesity surgery OR malabsorption disease OR receiving aromatase therapy for breast cancer who had a central dual-energy X-ray absorptiometry (DXA) ordered or performed or pharmacologic therapy prescribed within 12 months. 2009 Nov. NQMC:002957 American Academy of Family Physicians - Medical Specialty Society; American Academy of Orthopaedic Surgeons - Medical Specialty Society; American Association of Clinical Endocrinologists - Medical Specialty Society; American College of Rheumatology - Medical Specialty Society; National Committee for Quality Assurance - Health Care Accreditation Organization; Physician Consortium for Performance Improvement® - Clinical Specialty Collaboration; The Endocrine Society - Disease Specific Society. View all measures by the developer(s) Compare Selected 31. Breast cancer: percentage of patients for whom radiation therapy is administered within 1 year (365 days) of diagnosis for women under age 70 receiving breast conserving surgery for breast cancer. 2007 Apr. NQMC:002688 American Society of Clinical Oncology/National Comprehensive Cancer Network. View all measures by the developer(s) Compare Selected 32. Breast cancer: percentage of patients for whom tamoxifen or third generation aromatase inhibitor is considered or administered within 1 year (365 days) of diagnosis for women with AJCC T1c or stage II or III hormone receptor positive breast cancer. 2007 Apr. NQMC:002687 American Society of Clinical Oncology/National Comprehensive Cancer Network. View all measures by the developer(s) Compare Selected 21-32 of 32 < Previous